Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency | Business Wire

Links shared publicly online about this topic.

  • 0
    total visits

Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency | Business Wire

businesswire.com —

Pfizer Inc. (NYSE: PFE) announced today top-line results for Toviaz (fesoterodine fumarate) Study A0221048 – Effectiveness and Safety of a Flexi

View full resource at businesswire.com

Tags: Urinary System, Overactive Bladder, Overactive Bladder Medication, Toviaz, Pfizer, Bladder Dysfunction, Safety

  • Share

Most Recently Shared on November 8, 2011 at 3:42 pm By:

Bladder_OAB Overactive Bladder

Toviaz Top-Line Primary Endpoint Results Positive In Overactive Bladder Study Of Nocturnal Urinary Urgency: NEW ... http://t.co/Q2q1hVP0

6 months ago...

Reply

Retweet

Favorite

Also Shared By:

Urology & Nephrology Urology & Nephrology

Advertisement